Feasibility of neurosonography in CHD-fetuses and controls in a clinical tertiary setting

Objective: Ultrasonographic examination is the first-tier test to detect abnormal development of central nervous system (CNS). In optimal conditions, neurosonography can detect all important hallmarks of CNS development. It is, however, not known how the performance of this modality is in a routine...

Full description

Bibliographic Details
Main Authors: Sheila M. Everwijn, Jiska F. van Bohemen, Fenna A. Jansen, Sylke J. Steggerda, Aalbertine K. Teunissen, Monique C. Haak
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590161324000097
_version_ 1797253921260961792
author Sheila M. Everwijn
Jiska F. van Bohemen
Fenna A. Jansen
Sylke J. Steggerda
Aalbertine K. Teunissen
Monique C. Haak
author_facet Sheila M. Everwijn
Jiska F. van Bohemen
Fenna A. Jansen
Sylke J. Steggerda
Aalbertine K. Teunissen
Monique C. Haak
author_sort Sheila M. Everwijn
collection DOAJ
description Objective: Ultrasonographic examination is the first-tier test to detect abnormal development of central nervous system (CNS). In optimal conditions, neurosonography can detect all important hallmarks of CNS development. It is, however, not known how the performance of this modality is in a routine setting. We aimed to evaluate the feasibility of neurosonography in a time-limited routine setting. Study design: We have performed a prospective study in which we have included a group of pregnant women carrying a fetus with an isolated congenital heart defect (CHD), and a control group of fetuses without structural anomalies. We have performed basic neurosonography examination according to the guideline ‘how to perform a basic screening examination of the CNS’, published by the international society of ultrasound in obstetrics and gynecology in both groups. In all these examinations, 9 brain structures were scored in 3 different planes, by researchers that were blinded for group allocation. A sufficient neurosonogram was performed when 7 or more out of 9 CNS structures were clearly visible during the off-line scoring of the examination. Results: A total of 574 neurosonographic examinations were performed in 151 fetuses, 90 in the CHD-group and 61 in the control group. A sufficient neurosonogram could be performed in 79% (234/294) of cases in a clinical setting (CHD cases) and in 90% (253/280) of control pregnancies. Higher maternal BMI (>30), maternal age, fetal cephalic position, fetal gender and placental position did not significantly influence neurosonography scores. Conclusion: In clinical setting, basic fetal neurosonography can be sufficiently performed in the majority of cases. This was not significantly influenced by maternal or fetal factors. The optimal gestational age for neurosonography is between 22 and 34 weeks.
first_indexed 2024-03-08T00:09:21Z
format Article
id doaj.art-9c39c315bb714ffba6224c7257d0ac86
institution Directory Open Access Journal
issn 2590-1613
language English
last_indexed 2024-04-24T21:41:44Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series European Journal of Obstetrics & Gynecology and Reproductive Biology: X
spelling doaj.art-9c39c315bb714ffba6224c7257d0ac862024-03-21T05:37:36ZengElsevierEuropean Journal of Obstetrics & Gynecology and Reproductive Biology: X2590-16132024-03-0121100289Feasibility of neurosonography in CHD-fetuses and controls in a clinical tertiary settingSheila M. Everwijn0Jiska F. van Bohemen1Fenna A. Jansen2Sylke J. Steggerda3Aalbertine K. Teunissen4Monique C. Haak5Department of Obstetrics and Prenatal Diagnosis, Leiden University Medical Center, Leiden, the Netherlands; Correspondence to: Department of Obstetrics prenatal diagnosis and fetal therapy Leiden University Medical Center, Albinusdreef 2 2333 ZA Leiden, Postbus 9600 – 2300 RC, Leiden, the Netherlands.Department of Obstetrics and Prenatal Diagnosis, Leiden University Medical Center, Leiden, the NetherlandsDepartment of Obstetrics and Prenatal Diagnosis, Leiden University Medical Center, Leiden, the NetherlandsLeiden University Medical Center, Willem Alexander Children's Hospital, Department of Neonatology, Leiden, the NetherlandsDepartment of Obstetrics and Prenatal Diagnosis, Leiden University Medical Center, Leiden, the NetherlandsDepartment of Obstetrics and Prenatal Diagnosis, Leiden University Medical Center, Leiden, the NetherlandsObjective: Ultrasonographic examination is the first-tier test to detect abnormal development of central nervous system (CNS). In optimal conditions, neurosonography can detect all important hallmarks of CNS development. It is, however, not known how the performance of this modality is in a routine setting. We aimed to evaluate the feasibility of neurosonography in a time-limited routine setting. Study design: We have performed a prospective study in which we have included a group of pregnant women carrying a fetus with an isolated congenital heart defect (CHD), and a control group of fetuses without structural anomalies. We have performed basic neurosonography examination according to the guideline ‘how to perform a basic screening examination of the CNS’, published by the international society of ultrasound in obstetrics and gynecology in both groups. In all these examinations, 9 brain structures were scored in 3 different planes, by researchers that were blinded for group allocation. A sufficient neurosonogram was performed when 7 or more out of 9 CNS structures were clearly visible during the off-line scoring of the examination. Results: A total of 574 neurosonographic examinations were performed in 151 fetuses, 90 in the CHD-group and 61 in the control group. A sufficient neurosonogram could be performed in 79% (234/294) of cases in a clinical setting (CHD cases) and in 90% (253/280) of control pregnancies. Higher maternal BMI (>30), maternal age, fetal cephalic position, fetal gender and placental position did not significantly influence neurosonography scores. Conclusion: In clinical setting, basic fetal neurosonography can be sufficiently performed in the majority of cases. This was not significantly influenced by maternal or fetal factors. The optimal gestational age for neurosonography is between 22 and 34 weeks.http://www.sciencedirect.com/science/article/pii/S2590161324000097NeurosonographyUltrasound performanceCongenital heart defects
spellingShingle Sheila M. Everwijn
Jiska F. van Bohemen
Fenna A. Jansen
Sylke J. Steggerda
Aalbertine K. Teunissen
Monique C. Haak
Feasibility of neurosonography in CHD-fetuses and controls in a clinical tertiary setting
European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Neurosonography
Ultrasound performance
Congenital heart defects
title Feasibility of neurosonography in CHD-fetuses and controls in a clinical tertiary setting
title_full Feasibility of neurosonography in CHD-fetuses and controls in a clinical tertiary setting
title_fullStr Feasibility of neurosonography in CHD-fetuses and controls in a clinical tertiary setting
title_full_unstemmed Feasibility of neurosonography in CHD-fetuses and controls in a clinical tertiary setting
title_short Feasibility of neurosonography in CHD-fetuses and controls in a clinical tertiary setting
title_sort feasibility of neurosonography in chd fetuses and controls in a clinical tertiary setting
topic Neurosonography
Ultrasound performance
Congenital heart defects
url http://www.sciencedirect.com/science/article/pii/S2590161324000097
work_keys_str_mv AT sheilameverwijn feasibilityofneurosonographyinchdfetusesandcontrolsinaclinicaltertiarysetting
AT jiskafvanbohemen feasibilityofneurosonographyinchdfetusesandcontrolsinaclinicaltertiarysetting
AT fennaajansen feasibilityofneurosonographyinchdfetusesandcontrolsinaclinicaltertiarysetting
AT sylkejsteggerda feasibilityofneurosonographyinchdfetusesandcontrolsinaclinicaltertiarysetting
AT aalbertinekteunissen feasibilityofneurosonographyinchdfetusesandcontrolsinaclinicaltertiarysetting
AT moniquechaak feasibilityofneurosonographyinchdfetusesandcontrolsinaclinicaltertiarysetting